Crystal Phend on Muck Rack

Crystal Phend

San Francisco
As seen in: MedPage Today, MSN, ABC News, Flipboard, Medscape, Medscape Duestch, Medscape France, Medscape Noticias Médicas, Veterans Today, HealthLeaders, The Podcast by KevinMD
Contributing editor at MedPage Today. Views my own
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Crystal

Contact Crystal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Crystal Phend’s Biography

Read Full Bio →

Crystal Phend specialized in writing about medicine as a freelancer before she joined MedPage Today in 2006. Her byline has appeared in publications including The Medical Post, Oncology Times, Doctor's Guide, and the journal IDrugs. She holds a dual bachelor's degree in physical science and journalism from Cal Poly, San Luis Obispo. She is based in San Francisco.

Articles

Remibrutinib Resolves Symptoms of the Most Common Chronic Inducible Urticarias in Phase 3 Trial

|
By Crystal Phend
| Medscape Verified
Remibrutinib met its primary endpoints in achieving complete response criteria across the three most common subtypes of chronic inducible urticaria in the phase 3 RemIND trial. The oral, highly selective Bruton’s tyrosine kinase inhibitor roughly doubled the 12-week rate of complete response in symptomatic dermographism (29.3% vs 14%) and cholinergic urticaria (29.3% vs 15.8%), while the boost was even greater in cold urticaria (56.3% vs 14.6%).
Open in Who Shared Issue with article?

These ‘Repeat Offenders’ Trigger Most Contact Dermatitis From Wearable Diabetes Devices

|
By Crystal Phend
| Medscape Verified
Contact dermatitis from wearable diabetes devices often involves the same common compounds found in their adhesives, a new study showed. Among nearly four dozen youth with type 1 diabetes tested after having reactions to their continuous glucose monitors or continuous subcutaneous insulin infusion devices, 62.2% tested positive to at least one compound on a 15-allergen patch testing panel.
Open in Who Shared Issue with article?

ACC und AHA veröffentlichen erstmals Leitlinie zum kardiorenal-metabolischen Syndrom – die wichtigsten Empfehlungen

|
By Crystal Phend
| Medscape Duestch Verified
Neue interdisziplinäre Leitlinien zur Adipositas rücken erstmals die kardiovaskuläre, renale und metabolische Gesundheit als eng miteinander verknüpftes Krankheitsbild in den Mittelpunkt. Im Zentrum steht dabei das kardiorenal-metabolische Syndrom (KRMS) – ein noch vergleichsweise neues Konzept, das verschiedene medizinische Fachrichtungen zusammenführt, um diese eng verbundenen Gesundheitsprobleme frühzeitig zu erkennen und gezielt zu behandeln [1].
Open in Who Shared Issue with article?
See all 210 licensed articles (1,019 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified